tag:blogs.poz.com,2009-03-02:/tim//43 2013-05-09T19:04:45Z HIV Project Director, Treatment Action Group (TAG) Movable Type 4.34-en tag:blogs.poz.com,2013:/tim//43.400500 2013-05-09T13:14:08Z 2013-05-09T19:04:45Z

The United States is on course for some much-needed economic relief from the crippling cost of HIV treatment, with the anticipated arrival of generic versions of guidelines-preferred antiretrovirals. However, much preparation is required to maximize price competition, maintain patient choice, and ensure that savings are used to the advantage of people living with HIV.

Tim Horn http://blogs.poz.com/tim The United States is on course for some much-needed economic relief from the crippling cost of HIV treatment, with the anticipated arrival of generic versions of guidelines-preferred antiretrovirals. However, much preparation is required to maximize price competition, maintain patient choice, and ensure that savings are used to the advantage of people living with HIV. tag:blogs.poz.com,2012:/tim//43.400387 2012-12-14T17:10:05Z 2013-01-02T22:14:30Z

We have until January 4 to convince the United States Preventive Services Task Force to issue strong hepatitis C testing recommendations, in order to convince health care providers and insurers that it truly is a matter of life and death for hundreds of thousands of people unknowingly living with the life-threatening disease.

Tim Horn http://blogs.poz.com/tim We have until January 4 to convince the United States Preventive Services Task Force to issue strong hepatitis C testing recommendations, in order to convince health care providers and insurers that it truly is a matter of life and death for hundreds of thousands of people unknowingly living with the life-threatening disease. tag:blogs.poz.com,2012:/tim//43.400365 2012-11-10T19:19:23Z 2012-12-14T17:44:13Z

If we're going to make headway in terms of preventing and treating serious non-AIDS health complications among people living with HIV, which are very much on the rise and a serious risk to disease-free survival--not to mention cure the infection once and for all--we're going to need the full-on cooperation of pharmaceutical companies manufacturing drugs for other diseases that show potential for people living with HIV.

Tim Horn http://blogs.poz.com/tim If we're going to make headway in terms of preventing and treating serious non-AIDS health complications among people living with HIV, which are very much on the rise and a serious risk to disease-free survival--not to mention cure the infection once and for all--we're going to need the full-on cooperation of pharmaceutical companies manufacturing drugs for other diseases that show potential for people living with HIV. tag:blogs.poz.com,2012:/tim//43.400132 2012-05-04T16:30:03Z 2012-06-12T21:19:50Z

The national portrait of entry into and retention in HIV care has been consistently abysmal and the astounding dearth of data from well-designed studies exploring entry and retention strategies that could be used to construct well-formed recommendations is, perhaps, the final and most pressing frontier of HIV treatment advocacy in the United States.

Tim Horn http://blogs.poz.com/tim The national portrait of entry into and retention in HIV care has been consistently abysmal and the astounding dearth of data from well-designed studies exploring entry and retention strategies that could be used to construct well-formed recommendations is, perhaps, the final and most pressing frontier of HIV treatment advocacy in the United States. tag:blogs.poz.com,2011:/tim//43.32733 2011-03-29T16:50:06Z 2012-05-14T22:09:34Z

AIDS Healthcare Foundation's campaign against the FDA approval of Truvada as PrEP is misplaced. While there are numerous lingering questions regarding the efficacy, risks and accessibility of the drug as a tool in the HIV prevention chest, the PrEP genie is already out of the bottle. Community advocacy efforts are best directed at Gilead and public health agencies to ensure safe and affordable use.

Tim Horn http://blogs.poz.com/tim AIDS Healthcare Foundation's campaign against the FDA approval of Truvada as PrEP is misplaced. While there are numerous lingering questions regarding the efficacy, risks and accessibility of the drug as a tool in the HIV prevention chest, the PrEP genie is already out of the bottle. Community advocacy efforts are best directed at Gilead and public health agencies to ensure safe and affordable use. tag:blogs.poz.com,2010:/tim//43.3194 2010-12-30T20:37:18Z 2012-03-20T21:04:56Z

The second of a two-part look at the top treatment news of 2010.

Tim Horn http://blogs.poz.com/tim The second of a two-part look at the top treatment news of 2010. tag:blogs.poz.com,2010:/tim//43.3188 2010-12-27T16:31:28Z 2012-03-20T21:06:08Z

The first of a two-part look at the top treatment news of 2010.

Tim Horn http://blogs.poz.com/tim The first of a two-part look at the top treatment news of 2010. tag:blogs.poz.com,2010:/tim//43.3180 2010-12-17T17:09:50Z 2010-12-17T18:04:56Z

Scare tactics don't work, especially when the goal is to get people living with HIV who are unaware of their status tested and into care.

Tim Horn http://blogs.poz.com/tim Scare tactics don't work, especially when the goal is to get people living with HIV who are unaware of their status tested and into care. tag:blogs.poz.com,2010:/tim//43.3159 2010-11-30T14:03:24Z 2010-11-30T19:22:13Z

The international iPrEx study confirms that PrEP works, though not at the level researchers were initially hoping. The clinical trial, while encouraging, raises many more questions than answers.

Tim Horn http://blogs.poz.com/tim The international iPrEx study confirms that PrEP works, though not at the level researchers were initially hoping. The clinical trial, while encouraging, raises many more questions than answers. tag:blogs.poz.com,2010:/tim//43.3137 2010-11-12T15:30:15Z 2010-11-12T22:07:24Z

Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy. The question is, will a possible high price tag keep it out of the hands of those who need it?

Tim Horn http://blogs.poz.com/tim Egrifta (tesamorelin) has been approved for the treatment of HIV-associated lipodystrophy. The question is, will a possible high price tag keep it out of the hands of those who need it? tag:blogs.poz.com,2010:/tim//43.3106 2010-10-27T13:07:58Z 2010-10-27T18:51:16Z

For New York voters still torn between the gubernatorial front-runners, Democratic candidate Andrew Cuomo and Republican candidate Paladino, Gay Men's Health Crisis (GMHC) has issued a clear-eyed fact sheet spelling out the candidates' positions and work related to LGBT rights, HIV/AIDS prevention and care. Cuomo's and Paladino's views, past legislative actions, public statements and gubernatorial plans are outlined.

Tim Horn http://blogs.poz.com/tim For New York voters still torn between the gubernatorial front-runners, Democratic candidate Andrew Cuomo and Republican candidate Paladino, Gay Men's Health Crisis (GMHC) has issued a clear-eyed fact sheet spelling out the candidates' positions and work related to LGBT rights, HIV/AIDS prevention and care. Cuomo's and Paladino's views, past legislative actions, public statements and gubernatorial plans are outlined. tag:blogs.poz.com,2010:/tim//43.3060 2010-10-05T17:44:04Z 2010-10-05T19:21:45Z

A safe and affordable cure for HIV -- whether it's a single agent or, more realistically, a combination of modalities -- won't be on the U.S. Food and Drug Administration's doorstep anytime soon. However, it's slowly coming into view on the horizon, albeit still out of focus and without any defining shape. It's no longer a mirage, but something very real indeed.

Tim Horn http://blogs.poz.com/tim A safe and affordable cure for HIV -- whether it's a single agent or, more realistically, a combination of modalities -- won't be on the U.S. Food and Drug Administration's doorstep anytime soon. However, it's slowly coming into view on the horizon, albeit still out of focus and without any defining shape. It's no longer a mirage, but something very real indeed. tag:blogs.poz.com,2010:/tim//43.3055 2010-09-30T16:43:47Z 2010-10-06T15:30:48Z

Not everyone who has seen the recent IOM report suggesting a major overhaul of Social Security disability criteria are thrilled. Though it is clear that the IOM recommendations are only intended for new SSA disability applicants, there are concerns about how these new criteria will affect new applicants who may be relying on disability status, not only for income, but also health care and other supportive services.

Tim Horn http://blogs.poz.com/tim Not everyone who has seen the recent IOM report suggesting a major overhaul of Social Security disability criteria are thrilled. Though it is clear that the IOM recommendations are only intended for new SSA disability applicants, there are concerns about how these new criteria will affect new applicants who may be relying on disability status, not only for income, but also health care and other supportive services. tag:blogs.poz.com,2010:/tim//43.2948 2010-07-13T17:17:56Z 2010-07-13T23:18:40Z

In letters received over the weekend, the state Health Department told patients about new income guidelines for a program that enables thousands infected with HIV or diagnosed with AIDS to receive life-sustaining yet expensive antiretroviral drugs. As of Aug. 1, a patient's income cannot exceed $32,490, instead of the previous threshold of $54,150.

Tim Horn http://blogs.poz.com/tim In letters received over the weekend, the state Health Department told patients about new income guidelines for a program that enables thousands infected with HIV or diagnosed with AIDS to receive life-sustaining yet expensive antiretroviral drugs. As of Aug. 1, a patient's income cannot exceed $32,490, instead of the previous threshold of $54,150. tag:blogs.poz.com,2010:/tim//43.2904 2010-06-16T19:37:49Z 2010-06-17T01:53:43Z

On the evening of June 6th, my partner, Peter, and I made the inevitable trip to our nearby veterinary hospital to put our eldest boxer, Lucy, to sleep. She was 13 years old.

Tim Horn http://blogs.poz.com/tim On the evening of June 6th, my partner, Peter, and I made the inevitable trip to our nearby veterinary hospital to put our eldest boxer, Lucy, to sleep. She was 13 years old.